T
ARIA

TradeWorx’s Ariad Pharmaceuticals Inc ARIA Stock Holding History

TradeWorx’s Portfolio ARIA Stock Details ARIA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q1 		– Sell
-59,218
Closed -$404K – 636
2013
Q4 		$404K Buy
+59,218
New +$320K 0.18% 201

Other funds holding ARIA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
SPC
Slate Path Capital New York $6.73B AUM 95.97% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

TradeWorx's ARIA Position: Q1 2014 in Review

TradeWorx sold out of Ariad Pharmaceuticals Inc (ARIA) in Q1 2014, closing a stake of 59,218 shares — an estimated $404K sold.

TradeWorx first reported a position in ARIA in Q4 2013 and held it in 1 quarter. The position peaked at $404K in Q4 2013. 171 funds tracked by Wall St. Rank hold ARIA as of Q1 2014.

  • TradeWorx reported no remaining Ariad Pharmaceuticals Inc position as of Q1 2014 after selling out during the quarter.
  • TradeWorx sold 59,218 Ariad Pharmaceuticals Inc shares in Q1 2014, an estimated $404K.
  • TradeWorx first reported a position in Ariad Pharmaceuticals Inc in Q4 2013 and held it in 1 quarter.
  • TradeWorx's Ariad Pharmaceuticals Inc position peaked at $404K in Q4 2013.
  • 171 funds tracked by Wall St. Rank held Ariad Pharmaceuticals Inc as of Q1 2014.

Based on TradeWorx's 13F filing for Q1 2014, filed 2 Jun 2014.